ACAD
NASDAQ · Biotechnology
Acadia Pharmaceuticals Inc
$21.24
-0.23 (-1.07%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Price Target
Analyst Price Target
-15.7% upside
Low Target
$12.70
Average Target
$17.90
High Target
$23.84
Current Price
$21.24
Current
$21.24
$21.24
Target
$17.90
$17.90
$12.70
$17.90 avg
$23.84
Scenario Analysis
Bear Case
$12.70
-40.2%
Low target
Base Case
$17.90
-15.7%
Avg target
Bull Case
$23.84
+12.2%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$30.96
-31.4% from high
52-Week Low
$18.39
+15.5% from low
50-Day SMA
$23.20
-8.4% vs SMA
200-Day SMA
$23.60
-10.0% vs SMA
RSI (14)
67.0
Neutral
Target vs 52W High
$17.90
-42.2% vs high
Next Earnings Report
Nov 11, 2026
4d
until earnings
EPS Est: $0.20
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |